• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy

New research is stirring interest in ibogaine, which appears to help ease the agony of detox and prevent relapse. Used in other countries, it remains illegal in the U.S.

Andrew Jacobs
Author: Andrew Jacobs

Written by

Andrew Jacobs

in

Clinical Trials, Depression (Mental), Drug Abuse and Traffic, Drug Enforcement Administration, Drugs (Pharmaceuticals), Food and Drug Administration, Heart, Mental Health and Disorders, Opioids and Opiates, Pain-Relieving Drugs, Post-Traumatic Stress Disorder, Psychedelic and Hallucinogenic Drugs, Research, Therapy and Rehabilitation
←Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapy
Taylor Swift’s Singapore Shows Stir Anger in Southeast Asia→

More posts

  • Ex-assistant to fired Michigan coach speaks out

  • Tesla Cybercab production has begun

  • FDA grants quick review for 3 psychedelic drug trials

  • Ignoring the War Has Been Working for Long-Term Investors

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube